文献速递儿科与产科急症呼吸衰竭与机械通气

新生儿复苏中心率评估的新技术:系统综述

Novel technologies for heart rate assessment during neonatal resuscitation at birth - A systematic review.
PubMed 文献 · Resuscitation · 2019-07-19
一句话结论心电图较脉搏血氧饱和度更快评估新生儿出生时心率,但实践不应完全依赖心电图,新技术尚无临床疗效验证。

该系统综述遵循PRISMA指南,检索PubMed、EMBASE和Google Scholar,纳入46项评估新生儿复苏心率评估技术的研究,其中16项比较两种或以上技术。3项随机试验中1项低偏倚风险、2项高偏倚风险,所有观察性研究均为高偏倚风险,多数研究纳入不需复苏的婴儿,构成间接证据。两项试验报告心电图较脉搏血氧饱和度评估心率更快,平均(标准差)66(20)秒 vs 114(39)秒,中位数(四分位距)24(19-39)秒 vs 48(36-69)秒(均p<0.001)。结论认为心电图更快、更可靠检测心率变化,但实践不应完全依赖心电图,新技术尚无临床疗效验证。

要点

  • 心电图较脉搏血氧饱和度评估新生儿出生时心率更快:平均66秒 vs 114秒,中位24秒 vs 48秒(均p<0.001)。
  • 心电图较其他推荐技术更可靠检测心率变化,但实践不应完全依赖心电图。
  • 16项比较研究中仅3项为随机试验,其中1项低偏倚风险、2项高偏倚风险;所有观察性研究均为高偏倚风险。
  • 多数研究纳入不需复苏的婴儿,构成间接证据,在新生儿复苏背景下证据确定性较低。
  • 新技术可支持心率评估,但尚无研究验证其在新生儿复苏中的临床疗效。

适用人群与场景

  • 出生时可能需要复苏的新生儿;多数纳入研究为不需复苏的婴儿,构成间接证据。

研究设计与关键结果

  • 系统综述遵循PRISMA指南,检索PubMed、EMBASE和Google Scholar,纳入46项评估新生儿复苏心率评估技术的研究。
  • 16项研究(3项随机试验和13项观察性研究)比较两种或以上心率评估技术的准确度、延迟和效能;随机试验中1/3低偏倚风险、2/3高偏倚风险,所有观察性研究高偏倚风险。
  • 两项试验报告心电图较脉搏血氧饱和度评估心率更快:平均(标准差)66(20)秒 vs 114(39)秒,中位数(四分位距)24(19-39)秒 vs 48(36-69)秒(均p<0.001)。

证据类型、等级与局限

  • 证据类型:系统综述,纳入随机试验和观察性研究。
  • 随机试验中1/3低偏倚风险、2/3高偏倚风险;所有观察性研究均为高偏倚风险。
  • 多数研究纳入不需复苏的婴儿,构成间接证据,在新生儿复苏背景下证据确定性较低。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 心电图较脉搏血氧饱和度更快评估新生儿出生时心率,并可更可靠检测心率变化,但实践不应完全依赖心电图。
  • 新技术可支持心率评估,但尚无研究验证其在新生儿复苏中的临床疗效。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: 6.5-9 million newborns worldwide require resuscitation at birth annually. During neonatal resuscitation, inaccurate or slow heart rate (HR) assessments may significantly increase risk of infant mortality or morbidity. Therefore fast, accurate, and effective HR assessment tools are critical for neonatal resuscitation.

OBJECTIVE: To systematically review the literature about accuracy, latency, and efficacy of technologies for HR assessment during neonatal resuscitation.

METHODS: Adhering to PRISMA guidelines, PubMed, EMBASE, and Google Scholar databases were systematically searched to identify studies related to technologies for HR assessment, which could be used to guide neonatal resuscitation.

RESULTS: Forty-six studies evaluating HR assessment technologies for neonatal resuscitation were identified. In total, 16 studies (3/16 randomized trials and 13/16 observational studies) compared two or more HR assessment technologies to measure accuracy, latency, and efficacy. Of the trials, 1/3 had a low risk of bias while 2/3 had high risks. All observational studies had high risks of bias. Most studies considered infants not requiring resuscitation, constituting indirect evidence and lower certainty in the context of neonatal resuscitation. Two trials reported faster times to HR assessment using electrocardiogram with a mean(SD) 66(20) versus 114(39) s and a median(IQR) 24(19-39) versus 48(36-69) s (both p < 0.001), compared to pulse oximetry.

CONCLUSION: While electrocardiography is faster to assess HR at birth and more reliable to detect HR changes compared to other recommended technologies, practice should not exclusively rely on ECG. While novel technologies could support HR assessment, no studies validate their clinical efficacy during neonatal resuscitation.

来源:Resuscitation,查看原文。版权归原作者所有。

参考来源

  1. Johnson PA, Cheung PY, Lee TF, et al. Novel technologies for heart rate assessment during neonatal resuscitation at birth - A systematic review. Resuscitation. 2019. PMID: 31330200. doi:10.1016/j.resuscitation.2019.07.018

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。